Constitutive deficiency of the neurogenic hippocampal modulator AP2γ promotes anxiety-like behavior and cumulative memory deficits in mice from juvenile to adult periods
- University of Minho, Portugal
- Columbia University Medical Center, United States
Abstract
The transcription factor activating protein two gamma (AP2γ) is an important regulator of neurogenesis both during embryonic development as well as in the postnatal brain, but its role for neurophysiology and behavior at distinct postnatal periods is still unclear. In this work, we explored the neurogenic, behavioral, and functional impact of a constitutive and heterozygous AP2γ deletion in mice from early postnatal development until adulthood. AP2γ deficiency promotes downregulation of hippocampal glutamatergic neurogenesis, altering the ontogeny of emotional and memory behaviors associated with hippocampus formation. The impairments induced by AP2γ constitutive deletion since early development leads to an anxious-like phenotype and memory impairments as early as the juvenile phase. These behavioral impairments either persist from the juvenile phase to adulthood or emerge in adult mice with deficits in behavioral flexibility and object location recognition. Collectively, we observed a progressive and cumulative impact of constitutive AP2γ deficiency on the hippocampal glutamatergic neurogenic process, as well as alterations on limbic-cortical connectivity, together with functional behavioral impairments. The results herein presented demonstrate the modulatory role exerted by the AP2γ transcription factor and the relevance of hippocampal neurogenesis in the development of emotional states and memory processes.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting file;Source Data file has been provided for Figure 1.Source Code files have been provided for Figure 6 and for Figure 6 - Figure supplement 1.
Article and author information
Author details
Tiago Silveira-Rosa
Ana João Rodrigues
Funding
Fundação para a Ciência e a Tecnologia (SFRH/BD/131278/2017)
- Eduardo Loureiro-Campos
Fundação para a Ciência e a Tecnologia (UIDB/50026/2020 and UIDP/50026/2020)
- Eduardo Loureiro-Campos
- António Mateus-Pinheiro
- Joana Silva
- Vanessa Morais Sardinha
- Bárbara Mendes-Pinheiro
- Tiago Silveira-Rosa
- Ana Verónica Domingues
- Ana João Rodrigues
- João Oliveira
- Nuno Sousa
- Luísa Pinto
Fundação para a Ciência e a Tecnologia (PPBI-POCI-01-0145-FEDER-022122)
- Eduardo Loureiro-Campos
- António Mateus-Pinheiro
- Joana Silva
- Vanessa Morais Sardinha
- Bárbara Mendes-Pinheiro
- Tiago Silveira-Rosa
- Ana Verónica Domingues
- Ana João Rodrigues
- João Oliveira
- Nuno Sousa
- Luísa Pinto
Fundação para a Ciência e a Tecnologia (SRFH/BD/120124/2016)
- Bárbara Mendes-Pinheiro
Fundação para a Ciência e a Tecnologia (SFRH/BD/135273/2017)
- Tiago Silveira-Rosa
Fundação para a Ciência e a Tecnologia (SFRH/BD/147066/2019)
- Ana Verónica Domingues
Fundação para a Ciência e a Tecnologia (CEECIND/03887/2017)
- Carina Soares-Cunha
Fundação para a Ciência e a Tecnologia (IF/00328/2015,IF/01079/2014; PTDC/MED-NEU/31417/2017)
- João Oliveira
Fundação para a Ciência e a Tecnologia (2020.02855.CEECIND)
- Luísa Pinto
Fundação Bial (037/18)
- João Oliveira
Fundação Bial (427/14)
- Luísa Pinto
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Efforts were made to minimize the number of animals and their suffering. All experimental procedures performed in this work were conducted in accordance with the EU Directive 2010/63/EU and approved by the Portuguese National Authority for animal experimentation, Direção-Geral de Alimentação e Veterinária (DGAV) with the project reference 0420/000/000/2011 (DGAV 4542).
Copyright
© 2021, Loureiro-Campos et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,304
- views
-
- 152
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Constitutive deficiency of the neurogenic hippocampal modulator AP2γ promotes anxiety-like behavior and cumulative memory deficits in mice from juvenile to adult periods
eLife 10:e70685.
https://doi.org/10.7554/eLife.70685
Further reading
-
- Developmental Biology
- Genetics and Genomics
The establishment and growth of the arterial endothelium requires the coordinated expression of numerous genes. However, regulation of this process is not yet fully understood. Here, we combined in silico analysis with transgenic mice and zebrafish models to characterize arterial-specific enhancers associated with eight key arterial identity genes (Acvrl1/Alk1, Cxcr4, Cxcl12, Efnb2, Gja4/Cx37, Gja5/Cx40, Nrp1 and Unc5b). Next, to elucidate the regulatory pathways upstream of arterial gene transcription, we investigated the transcription factors binding each arterial enhancer compared to a similar assessment of non-arterial endothelial enhancers. These results found that binding of SOXF and ETS factors was a common occurrence at both arterial and pan-endothelial enhancers, suggesting neither are sufficient to direct arterial specificity. Conversely, FOX motifs independent of ETS motifs were over-represented at arterial enhancers. Further, MEF2 and RBPJ binding was enriched but not ubiquitous at arterial enhancers, potentially linked to specific patterns of behaviour within the arterial endothelium. Lastly, there was no shared or arterial-specific signature for WNT-associated TCF/LEF, TGFβ/BMP-associated SMAD1/5 and SMAD2/3, shear stress-associated KLF4 or venous-enriched NR2F2. This cohort of well characterized and in vivo-verified enhancers can now provide a platform for future studies into the interaction of different transcriptional and signalling pathways with arterial gene expression.
-
- Developmental Biology
- Genetics and Genomics
Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.
